STAT1 and rheumatoid arthritis: Transcription factors STAT1 and STAT2 are activated by interferons and are common targets in studies of potential therapeutics for OA and rheumatoid arthritis (Li et al., 2001; Legendre et al., 2003; Millward-Sadler et al., 2006; Dai et al., 2018).